In a study of Wegovy in people with or without type 2 diabetes, people taking 1.7 mg and 2.4 mg dosages lost an average of 2% of their body weight after one month
Month 2-3 (0.5-1.0 mg): An additional 4-8 pounds
It mimics the naturally occurring GLP-1 hormone that your intestines produce after eating
Semaglutide Dosing Guide In-depth dosing protocols, clinical trial data, and pharmacokinetics
However, a thorough evaluation by our healthcare provider is necessary to determine if you are a suitable candidate, as they will consider your medical history, current health status, and any potential risks or contraindications
The temporal association between starting semaglutide and developing joint symptoms may be coincidental rather than causal, highlighting the importance of thorough clinical evaluation